Bajaj Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/10/2026 ,inter alia, to consider and approve the un-audited financial results for the quarter and half year ended 30th September 2026

Ref: BHL/ STEX 40/ 2026-27 Date: October 09, 2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers 5th Floor, Exchange Plaza, Dalal Street Bandra Kurla Complex Bandra (East) Mumbai – 400001 Mumbai-400051 Scrip Code: 539872 Symbol: BAJAJHCARE Sub: Intimation of Board Meeting Dear Sir/Madam, Pursuant to Regulation 29 of Securities & Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Saturday, October 17, 2026, inter alia, to consider and approve Un- audited Financial Results of the Company for the quarter and half year ended September 30, 2026. Further, in continuation of our earlier notice dated September 23, 2026 and pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company’s Code of Conduct for Regulating, Monitoring and Reporting of Trading in Securities by the Insiders, the Trading Window for dealing in securities of the Company shall remain closed for all Insiders, Designated Persons including their immediate relatives from October 01, 2026 till the expiry of 48 hours after the declaration of Un-audited Financial Results for the quarter and half year ended September 30, 2026. You are requested to take the same on record. Thanking you. Yours faithfully, For and on behalf of Bajaj Healthcare Limited Monica Tanwar Company Secretary & Compliance Officer